Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 4 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 12076347

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  2. US 12053569

    Indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  3. US 12054744

    NK cells exhibiting an adaptive phenotype and methods for preparing and for using

    Regents of the University of Minnesota · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  4. US 12049642

    Corneal endothelial cells with increased cell density and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  5. US 12049645

    Differentiation of pancreatic endocrine cells

    Vertex Pharmaceuticals Incorporated · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  6. US 12037607

    Methods of preparing hematopoietic progenitor cells in vitro

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  7. US 12036243

    BCMA CAR-T cells with enhanced activities

    Allogene Therapeutics, Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  8. US 12037410

    Methods and compositions for targeting Treg cells

    PRECISION BIOLOGICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  9. US 12018081

    Photoconjugation reactions for modification of specific proteins on live cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  10. US 12005080

    Method for promoting proliferation of immune cells

    Oricell Therapeutics Co., Ltd. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  11. US 12006516

    Differentiation of pancreatic endocrine cells

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  12. US 11998571

    Pharmaceutical composition comprising stem cell-conditioned medium and exosome isolated therefrom as active ingredient for prevention or treatment of ocular disease

    DESIGNED CELLS CO., LTD. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  13. US 11976126

    Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

    Inhibrx, Inc. · Granted May 7, 2024 · Expires May 2, 2044

    granted
  14. US 11976299

    Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2024 · Expires May 2, 2044

    granted
  15. US 11964021

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  16. US 11965161

    Methods and compositions for sensitization of tumor cells to immune therapy

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  17. US 11959096

    Methods for selective inhibition of pluripotent stem cells

    The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services NIH, Office of Technology Transfer · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  18. US 11958908

    Compositions and methods for the depletion of CD117+ cells

    CRISPR THERAPEUTICS AG · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  19. US 11944644

    T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  20. US 11931337

    Compound antioxidant preparation for reducing the number of somatic cells in a livestock animal and a preparation method and application thereof

    China Agricultural University · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  21. US 11932871

    Methods of culturing t cells and uses of same

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  22. US 11932703

    Anti-ROR1 antibody and ROR1-targeting engineered cells

    Caribou Biosciences, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  23. US 11926676

    Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

    CRISPR THERAPEUTICS AG · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  24. US 11918640

    Methods of preparing anti-human papillomavirus antigen T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted